[1]
Verbeeck, R.K. et al. 2015. The Lidose Hard Capsule Formulation of Fenofibrate is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-fat Fed Conditions. Journal of Pharmacy & Pharmaceutical Sciences. 18, 1 (Feb. 2015), 61–67. DOI:https://doi.org/10.18433/J3FG7G.